| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:57:55 UTC |
|---|
| Update Date | 2022-11-30 19:25:57 UTC |
|---|
| HMDB ID | HMDB0114877 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(18:0/16:1(9Z)) |
|---|
| Description | PA(18:0/16:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCC InChI=1S/C37H71O8P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-36(38)43-33-35(34-44-46(40,41)42)45-37(39)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h14,16,35H,3-13,15,17-34H2,1-2H3,(H2,40,41,42)/b16-14-/t35-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Octadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate | ChEBI | | 1-Stearoyl-2-palmitoleoyl-sn-glycero-3-phosphate | ChEBI | | 1-Octadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoric acid | Generator | | 1-Stearoyl-2-palmitoleoyl-sn-glycero-3-phosphoric acid | Generator | | 1-Stearoyl-2-palmitoleoyl-sn-phosphatidic acid | HMDB | | PA(18:0/16:1) | HMDB | | PA(18:0/16:1N7) | HMDB | | PA(18:0/16:1W7) | HMDB | | PA(34:1) | HMDB | | Phosphatidic acid(18:0/16:1(9Z)) | HMDB | | Phosphatidic acid(18:0/16:1) | HMDB | | Phosphatidic acid(18:0/16:1n7) | HMDB | | Phosphatidic acid(18:0/16:1W7) | HMDB | | Phosphatidic acid(34:1) | HMDB | | Phosphatidate(18:0/16:1(9Z)) | HMDB | | Phosphatidate(18:0/16:1) | HMDB | | Phosphatidate(18:0/16:1N7) | HMDB | | Phosphatidate(18:0/16:1W7) | HMDB | | Phosphatidate(34:1) | HMDB | | 1-stearoyl-2-palmitoleoyl-sn-glycero-3-phosphate | SMPDB, ChEBI | | 1-stearoyl-2-palmitoleoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(18:0/16:1) | SMPDB, HMDB | | PA(18:0/16:1n7) | SMPDB, HMDB | | PA(18:0/16:1w7) | SMPDB, HMDB | | PA(34:1) | SMPDB, HMDB | | Phosphatidic acid(18:0/16:1(9Z)) | SMPDB, HMDB | | Phosphatidic acid(18:0/16:1) | SMPDB, HMDB | | Phosphatidic acid(18:0/16:1n7) | SMPDB, HMDB | | Phosphatidic acid(18:0/16:1w7) | SMPDB, HMDB | | Phosphatidic acid(34:1) | SMPDB, HMDB | | Phosphatidate(18:0/16:1(9Z)) | SMPDB, HMDB | | Phosphatidate(18:0/16:1) | SMPDB, HMDB | | Phosphatidate(18:0/16:1n7) | SMPDB, HMDB | | Phosphatidate(18:0/16:1w7) | SMPDB, HMDB | | PA(18:0/16:1(9Z)) | SMPDB, ChEBI |
|
|---|
| Chemical Formula | C37H71O8P |
|---|
| Average Molecular Weight | 674.9286 |
|---|
| Monoisotopic Molecular Weight | 674.48865576 |
|---|
| IUPAC Name | [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCC |
|---|
| InChI Identifier | InChI=1S/C37H71O8P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-36(38)43-33-35(34-44-46(40,41)42)45-37(39)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h14,16,35H,3-13,15,17-34H2,1-2H3,(H2,40,41,42)/b16-14-/t35-/m1/s1 |
|---|
| InChI Key | NLVQCMNLQFFKPE-WMHOIYFHSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/16:0) (PathBank: SMP0069416)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/18:1(9Z)) (PathBank: SMP0069420)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0069422)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(11Z)/18:1(11Z)) (PathBank: SMP0069436)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(9Z)/16:1(9Z)) (PathBank: SMP0069438)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(9Z)/18:0) (PathBank: SMP0069439)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)) (PathBank: SMP0069452)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0) (PathBank: SMP0069457)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/18:1(11Z)) (PathBank: SMP0078168)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0078170)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0078172)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/18:1(11Z)) (PathBank: SMP0078176)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0078179)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(9Z)/18:1(11Z)) (PathBank: SMP0078189)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:2(9Z,12Z)/18:0) (PathBank: SMP0078192)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:0) (PathBank: SMP0078195)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078200)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)) (PathBank: SMP0078205)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078207)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/16:1(9Z)) (PathBank: SMP0093447)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0093454)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(11Z)/18:1(9Z)) (PathBank: SMP0093458)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(9Z)/18:1(9Z)) (PathBank: SMP0093462)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0093468)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)) (PathBank: SMP0093469)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:0) (PathBank: SMP0093470)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:0) (PathBank: SMP0093474)
- Phospholipid Biosynthesis CL(18:0/16:1(9Z)/18:0/16:1(9Z)) (PathBank: SMP0122067)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0069425)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/18:2(9Z,12Z)) (PathBank: SMP0069429)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0069432)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:2(9Z,12Z)/16:1(9Z)) (PathBank: SMP0069442)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) (PathBank: SMP0069445)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0078193)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0078204)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0093445)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/18:1(9Z)) (PathBank: SMP0093449)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0093471)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0069431)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(11Z)/16:1(9Z)) (PathBank: SMP0069434)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/18:1(11Z)/18:0) (PathBank: SMP0069435)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0069454)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/16:1(9Z)) (PathBank: SMP0078166)
- Cardiolipin Biosynthesis CL(18:0/16:1(9Z)/16:1(9Z)/18:0) (PathBank: SMP0069418)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:0) (PathBank: SMP0018419)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:0) (PathBank: SMP0018420)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/24:0) (PathBank: SMP0018421)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/14:1(9Z)) (PathBank: SMP0018422)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/16:1(9Z)) (PathBank: SMP0018423)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:0) (PathBank: SMP0018425)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:1(9Z)) (PathBank: SMP0018426)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:1(11Z)) (PathBank: SMP0018427)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0018428)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:1(13Z)) (PathBank: SMP0018429)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/24:1(15Z)) (PathBank: SMP0018430)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0018431)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0018432)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0018433)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:2(13Z,16Z)) (PathBank: SMP0018434)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0018435)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0018436)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0018437)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0018438)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0018439)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0018440)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0018441)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0018442)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/18:1(11Z)) (PathBank: SMP0030240)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:2(11Z,14Z)) (PathBank: SMP0032941)
- De Novo Triacylglycerol Biosynthesis TG(18:0/16:1(9Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0032942)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 10.1 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 32.3519 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.03 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 4827.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 509.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 345.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 225.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 981.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1635.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1352.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 247.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3277.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1038.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2682.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1242.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 679.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 645.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 759.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(18:0/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4726.8 | Semi standard non polar | 33892256 | | PA(18:0/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4227.2 | Standard non polar | 33892256 | | PA(18:0/16:1(9Z)),1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5655.5 | Standard polar | 33892256 | | PA(18:0/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4700.5 | Semi standard non polar | 33892256 | | PA(18:0/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4214.3 | Standard non polar | 33892256 | | PA(18:0/16:1(9Z)),2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4903.5 | Standard polar | 33892256 | | PA(18:0/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4973.9 | Semi standard non polar | 33892256 | | PA(18:0/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4333.1 | Standard non polar | 33892256 | | PA(18:0/16:1(9Z)),1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5635.3 | Standard polar | 33892256 |
|
|---|